Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Ferric pyrophosphate (Primary) ; Ferric pyrophosphate
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Rockwell Medical Technologies
- 30 Oct 2017 According to a Rockwell Medical India media release, data from the study will be presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.
- 04 Aug 2017 Status changed from not yet recruiting to completed.
- 29 Sep 2016 New trial record